Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Standard Diagnosis and Treatment for HSPN in Children
NCT02532777Phase 2Unknown
- Sponsor
- Children's Hospital of Nanjing Medical University
- Start
- Aug 2015
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide, mycophenolate mofetil, leflunomide in Henoch-Schönlein purpura nephritis (HSPN), sponsored by Children's Hospital of Nanjing Medical University. Status: unknown.
02
Drugs
cyclophosphamidemycophenolate mofetilleflunomide
03
Conditions
Henoch-Schönlein purpura nephritis (HSPN)
Beyond the preview
Go deeper on NCT02532777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02532777.